HomeCompanies › MBRX

Moleculin Biotech

Most recent annual filing: 2026-03-18

Catalyst timeline

7 trackedQuarter catalyst calendar →
  1. Annamycin filing3Q 2026Annamycin filing, 3Q 2026, notable
  2. WP1066 readout2H 2026WP1066 readout, 2H 2026, notable
  3. Annamycin pancreatic Ph1 start2H 2026Annamycin pancreatic Ph1 start, 2H 2026, routine
  4. Annamycin enrollment doneSep 2026Annamycin enrollment done, Sep 2026, routine
  5. Annamycin toplineDec 2026 – Feb 2027Annamycin topline, Dec 2026 – Feb 2027, thesis-defining
  6. Annamycin Ph3 start1H 2027Annamycin Ph3 start, 1H 2027, routine
  7. Annamycin financingJan 30, 2027Annamycin financing, Jan 30, 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (10 active programs)

Discontinued (5)

Biotech Distilled coverage (2)

Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.